Symbols

AVDL(Delisted)

Avadel Pharmaceuticals·NASDAQ

--(--)

AVDL fundamentals

AVDL Q2 2025 Earnings

Avadel Pharmaceuticals (AVDL) released its earnings on Aug 7, 2025: revenue was 68.13M (YoY +64.15%), beat estimates; EPS was 0.1 (YoY +171.43%), beat estimates.

Revenue / YoY

68.13M

+64.15%

EPS / YoY

0.1

+171.43%

Report date

Aug 7, 2025

AVDL Earnings Call Summary for Q2,2025

Revenue and Profitability: Q2 net revenue $68.1M (+64% YoY), first quarterly net income $9.7M, and full-year guidance raised to $265M-$275M.
Patient Growth: 3,100 active patients (+63% YoY), with 64% YoY revenue growth and 63% new patient starts YoY.
IH Expansion: Phase III IH trial nearing completion, targeting 2026 data readout for 42,000 IH patients (11% treated).
Litigation Strength: Court affirmed LUMRYZ's superiority; antitrust trial seeks >$1B recovery.
Operational Efficiency: 30% sequential revenue growth, 32% gross profit growth, and $15M cash generation.

Earnings

EPS

Revenue

Revenue & Expenses

AVDL has released its 2025 Q3 earnings report, with revenue of 77.47M, reflecting a YoY change of 54.86%, and net profit of 20.00K, showing a YoY change of 100.76%. The Sankey diagram below clearly presents AVDL's revenue sources and cost distribution.

Key Indicators

Avadel Pharmaceuticals (AVDL) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Avadel Pharmaceuticals (AVDL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Avadel Pharmaceuticals (AVDL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Avadel Pharmaceuticals (AVDL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Avadel Pharmaceuticals (AVDL) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Avadel Pharmaceuticals (AVDL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data